Related Experiment Video
Updated: Jul 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Chronic hepatitis C virus infection: is there a correlation between HCV genotypes and the level of viremia?]
Dragan Delić1, Zorica Nesić, Jasmina Simonović
1Klinicki centar Srbije, Institut za infektivne i tropske bolesti, Beograd. infectro@eunet.yu
Insights
Hepatitis C virus (HCV) genotype 1b is predominant in Europe and associated with higher viral loads and more severe disease. This necessitates longer treatment durations, posing economic challenges.
Area of Science:
- Virology
- Hepatology
- Infectious Diseases
Context:
- Hepatitis C virus (HCV) RNA status and genotypes are crucial for diagnosing, prognosing, and managing chronic HCV infections.
- Accurate virologic assessment aids in tailoring antiviral therapy and monitoring treatment efficacy.
Purpose:
- To precisely assess virologic analyses, including HCV RNA quantification and genotyping, in patients with chronic HCV infection.
- To determine the prevalence of different HCV genotypes and their correlation with viral load and patient demographics.
Summary:
- A study of 110 chronic HCV patients utilized PCR for genotyping and RNA quantification.
- Hepatitis C virus (HCV) genotype 1b was most prevalent (49.1%), followed by genotype 3a (28.2%).
- Patients with genotype 1b exhibited significantly higher serum HCV RNA levels compared to other genotypes, with over 70% having >2 x 10^6 copies/ml.
Impact:
- Genotype 1b is the predominant HCV genotype in Europe, linked to higher viremia and potentially more severe clinical courses.
- Higher viral loads in genotype 1b infections may necessitate extended treatment durations (48 weeks), leading to economic concerns.
- Understanding genotype prevalence and viral load is essential for effective HCV management strategies and public health planning.
Introduction:
Hepatitis C virus (HCV) RNA status and HCV genotypes have become extremely important for exact diagnosis, prognosis, duration of treatment and monitoring of antiviral therapy of chronic HCV infection.
Material And Methods:
For the purpose of precise and objective assessment of virologic analyses, such as the determination of the number of virus copies and virus genotypes, 110 patients with chronic HCV infection were tested Genotyping of HCV isolates and HCV RNA quantification were performed by using the PCR method. Genotype 1b infection was verified in 49.1% of patients, genotype 3a infection was found in 28.2%, genotype 4 in 9.1%, genotype 2 in 4.5%, while mixed genotype infections were diagnosed in 9.1% of cases.
Results:
Patients infected by genotype 1b had significantly higher serum HCV RNA level in relation to patients infected by other genotypes (p < 0.05). Over 70% of patients infected by genotype 1b had more than 2 x 10(6) virus copies in 1 ml of blood, while in genotypes 2, 3a and 4, the percentage was 40%, 38.5% and 30%, respectively. Male patients had approximately 7.7 x 10(6) virus copies in 1 ml of blood, which was significantly higher in comparison with female patients (2.3 x 10(6) copies/ml; p < 0.05).
Conclusion:
Our results are in concordance with the results of other authors reporting that genotype 1b is predominant in Europe, as well as significantly higher incidence of viremia in patients with genotype 1b infection in relation to other HCV genotypes. Based on these results, we can conclude that our patients, most commonly, present with severe clinical course of chronic HCV infection and require longer treatment (48 weeks), which causes economic problems.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Human Virome
Viruses with RNA Genomes
Size and Structure of Viral Genomes

